In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Global Medical REIT Inc (NYSE: GMRE) closed the day trading at $33.57 down -6.93% from the previous closing price of $36.07. In other words, the price has decreased by -$6.93 from its previous closing price. On the day, 0.5 million shares were traded. GMRE stock price reached its highest trading level at $35.85 during the session, while it also had its lowest trading level at $33.54.
Ratios:
For a better understanding of GMRE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 1.46 whereas as Long-Term Debt/Eq ratio is at 1.43.
On October 18, 2024, Berenberg started tracking the stock assigning a Buy rating and target price of $11.75.
On September 19, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $12.Alliance Global Partners initiated its Buy rating on September 19, 2024, with a $12 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 26 ’25 when Cypher Matthew bought 1,350 shares for $7.38 per share. The transaction valued at 9,960 led to the insider holds 1,350 shares of the business.
Barber Jamie Allen sold 130,000 shares of GMRE for $861,068 on Aug 15 ’25. The General Counsel and Secretary now owns 0 shares after completing the transaction at $6.62 per share. On Aug 15 ’25, another insider, Decker Mark Okey Jr, who serves as the CEO and President of the company, bought 17,023 shares for $6.87 each. As a result, the insider paid 116,948 and bolstered with 190,894 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMRE now has a Market Capitalization of 914149248 and an Enterprise Value of 1255410816. As of this moment, Global’s Price-to-Earnings (P/E) ratio for their current fiscal year is 99.76, and their Forward P/E ratio for the next fiscal year is 71.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.13 while its Price-to-Book (P/B) ratio in mrq is 1.05. Its current Enterprise Value per Revenue stands at 8.847 whereas that against EBITDA is 14.566.
Stock Price History:
The Beta on a monthly basis for GMRE is 1.23, which has changed by 2.4185336 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, GMRE has reached a high of $49.90, while it has fallen to a 52-week low of $30.27. The 50-Day Moving Average of the stock is -6.05%, while the 200-Day Moving Average is calculated to be -10.67%.
Shares Statistics:
Over the past 3-months, GMRE traded about 165.75K shares per day on average, while over the past 10 days, GMRE traded about 387826 shares per day. Shares short for GMRE as of 1756425600 were 558370 with a Short Ratio of 3.37, compared to 1753920000 on 498011. Therefore, it implies a Short% of Shares Outstanding of 558370 and a Short% of Float of 0.89.
Dividends & Splits
GMRE’s forward annual dividend rate is 3.35, up from 3.9 a year ago. Against a Trailing Annual Dividend Yield of 0.108123094. The stock’s 5-year Average Dividend Yield is 7.99. The current Payout Ratio is 6829.27% for GMRE, which recently paid a dividend on 2025-06-20 with an ex-dividend date of 2025-09-29. Stock splits for the company last occurred on 2025-09-22 when the company split stock in a 1:5 ratio.
Earnings Estimates
Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is $0.05, with high estimates of $0.1 and low estimates of $0.0.
Analysts are recommending an EPS of between $4.15 and $4.15 for the fiscal current year, implying an average EPS of $4.15. EPS for the following year is $4.35, with 1.0 analysts recommending between $4.35 and $4.35.
Revenue Estimates
4 analysts predict $38.15M in revenue for. The current quarter. It ranges from a high estimate of $38.61M to a low estimate of $37.86M. As of. The current estimate, Global Medical REIT Inc’s year-ago sales were $34.26MFor the next quarter, 4 analysts are estimating revenue of $37.97M. There is a high estimate of $39.34M for the next quarter, whereas the lowest estimate is $36.38M.
A total of 6 analysts have provided revenue estimates for GMRE’s current fiscal year. The highest revenue estimate was $150.42M, while the lowest revenue estimate was $143M, resulting in an average revenue estimate of $146.8M. In the same quarter a year ago, actual revenue was $138.78MBased on 5 analysts’ estimates, the company’s revenue will be $153.53M in the next fiscal year. The high estimate is $164.68M and the low estimate is $147.97M.
